PIII — P3 Health Partners Cashflow Statement
0.000.00%
Last trade - 00:00- $18.32m
- $281.72m
- $1.46bn
Annual cashflow statement for P3 Health Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -204 | -1,562 | -186 | -310 | -323 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 53.4 | 1,313 | -6.69 | 27.3 | 62.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 75.8 | 35.2 | 30.4 | 88 | 81.9 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -66.5 | -126 | -76 | -110 | -91.2 |
| Capital Expenditures | -3.41 | -2.23 | -1.83 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -52.7 | -5.5 | 0 | 14.5 | 0.129 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -56.1 | -7.73 | -1.83 | 14.5 | 0.129 |
| Financing Cash Flow Items | — | — | -0.364 | -0.68 | -0.186 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 223 | 11.4 | 100 | 98.8 | 72.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 101 | -122 | 22.5 | 3.17 | -18.3 |